The Digital Source For China's Tech Innovation Since 2000

Search
Close

Sinovac Biotech Commences SARS Vaccine Phase I Human Clinical Testing

May 24, 2004
Science

Sinovac Biotech Ltd. (Sinovac) announced that it has commenced Phase I human clinical trials of its SARS vaccine.

The first subjects were injected with the vaccine on the 22nd of May 2004 at the Sino-Japan Friendship Hospital in Beijing. More details will follow in a follow-up Sinovac news release on 24th May 2004. Sinovac specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as Hepatitis A and Hepatitis B, influenza and SARS.

Tags: Beijing | Biotech | development | hospital | influenza | IT | Japan | medicine | news | research | sales | SARS | technology | testing | Vaccine

Other Related News:

EDICON Across China 2022 Announces Keynote Speakers for Its EDICON China Online Forum on April 26-27

February 12, 2022

PAS Service Will Die In China Within Three Years

February 5, 2009

Hong Kong Concludes Bids For Radio Spectrum Auction

June 15, 2009

Sina To Report Q1 2004 Financial Results

April 16, 2004

Dust off your flip-flops for a family vacation package in Sanya

September 16, 2010

Lenovo to raise $1.5bn on Shanghai STAR market

October 2, 2021

Chinese Internet Revenue Rises While Profit Goes Down For Sohu.com

April 26, 2010

18,000 Shares in KraneShares CSI China Internet ETF (NYSEARCA:KWEB) Bought by Global Endowment Management LP

May 9, 2022

VMware patches released after vulnerabilities found during Tianfu Cup reported by Chinese gov't Malware News Malware Analysis, News and Indicators

February 16, 2022
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
Menu
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
© 2022 ChinaTechNews.com. A Service of Asia Media Network.
Twitter
Posting....